Capital Advisors Ltd’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $118K | Sell |
225
-3
| -1% | -$1.68K | 0.01% | 368 |
|
|
2026
Q1 | $128K | Hold |
228
| – | – | 0.01% | 345 |
|
|
2025
Q4 | $154K | Hold |
228
| – | – | 0.02% | 314 |
|
|
2025
Q3 | $146K | Buy |
228
+3
| +1% | +$1.82K | 0.02% | 317 |
|
|
2025
Q2 | $121K | Sell |
225
-13
| -5% | -$6.22K | 0.01% | 328 |
|
|
2025
Q1 | $100K | Sell |
238
-4
| -2% | -$1.74K | 0.01% | 341 |
|
|
2024
Q4 | $100K | Buy |
242
+4
| +2% | +$1.75K | 0.01% | 340 |
|
|
2024
Q3 | $120K | Hold |
238
| – | – | 0.01% | 322 |
|
|
2024
Q2 | $116K | Buy |
238
+5
| +2% | +$2.51K | 0.02% | 325 |
|
|
2024
Q1 | $126K | Buy |
233
+1
| +0.4% | +$546 | 0.02% | 323 |
|
|
2023
Q4 | $129K | Hold |
232
| – | – | 0.02% | 311 |
|
|
2023
Q3 | $101K | Sell |
232
-5
| -2% | -$2.49K | 0.02% | 329 |
|
|
2023
Q2 | $119K | Buy |
237
+1
| +0.4% | +$479 | 0.02% | 319 |
|
|
2023
Q1 | $118K | Buy |
236
+1
| +0.4% | +$479 | 0.02% | 298 |
|
|
2022
Q4 | $96K | Buy |
235
+20
| +9% | +$7.76K | 0.02% | 319 |
|
|
2022
Q3 | $70K | Buy |
215
+3
| +1% | +$1.1K | 0.01% | 336 |
|
|
2022
Q2 | $74K | Hold |
212
| – | – | 0.01% | 326 |
|
|
2022
Q1 | $116K | Sell |
212
-1
| -0.5% | -$526 | 0.02% | 299 |
|
|
2021
Q4 | $140K | Buy |
213
+1
| +0.5% | +$628 | 0.02% | 265 |
|
|
2021
Q3 | $132K | Hold |
212
| – | – | 0.02% | 253 |
|
|
2021
Q2 | $134K | Hold |
212
| – | – | 0.02% | 242 |
|
|
2021
Q1 | $104K | Sell |
212
-548
| -72% | -$275K | 0.02% | 237 |
|
|
2020
Q4 | $218K | Buy |
760
+548
| +258% | +$245K | 0.05% | 164 |
|
|
2020
Q3 | $83K | Hold |
212
| – | – | 0.02% | 232 |
|
|
2020
Q2 | $70K | Hold |
212
| – | – | 0.02% | 250 |
|
|
2020
Q1 | $51K | Sell |
212
-113
| -35% | -$29.5K | 0.02% | 256 |
|
|
2019
Q4 | $85K | Hold |
325
| – | – | 0.02% | 222 |
|
|
2019
Q3 | $88K | Sell |
325
-175
| -35% | -$48.7K | 0.02% | 209 |
|
|
2019
Q2 | $138K | Hold |
500
| – | – | 0.04% | 178 |
|
|
2019
Q1 | $112K | Hold |
500
| – | – | 0.03% | 206 |
|
|
2018
Q4 | $93K | Hold |
500
| – | – | 0.03% | 213 |
|
|
2018
Q3 | $125K | Hold |
500
| – | – | 0.04% | 194 |
|
|
2018
Q2 | $109K | Hold |
500
| – | – | 0.03% | 172 |
|
|
2018
Q1 | $96K | Hold |
500
| – | – | 0.03% | 181 |
|
|
2017
Q4 | $78K | Sell |
500
-125
| -20% | -$19.7K | 0.03% | 192 |
|
|
2017
Q3 | $97K | Sell |
625
-170
| -21% | -$26.9K | 0.03% | 173 |
|
|
2017
Q2 | $128K | Buy |
+795
| New | +$129K | 0.05% | 149 |
|
Other funds holding IDXX
Capital Advisors Ltd's IDXX Position: Q2 2026 in Review
Capital Advisors Ltd reduced its Idexx Laboratories (IDXX) stake by 1.3% in Q2 2026, selling an estimated $1.68K and leaving 225 shares worth $118K. The position accounts for 0.01% of the portfolio, ranked #368.
Capital Advisors Ltd first reported a position in IDXX in Q2 2017 and has held it in 37 quarters since. The position peaked at $218K in Q4 2020. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Capital Advisors Ltd held 225 shares of Idexx Laboratories worth $118K as of Q2 2026.
- Capital Advisors Ltd sold 3 Idexx Laboratories shares in Q2 2026, an estimated $1.68K.
- Idexx Laboratories made up 0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #368 holding.
- Capital Advisors Ltd first reported a position in Idexx Laboratories in Q2 2017 and has held it in 37 quarters since.
- Capital Advisors Ltd's Idexx Laboratories position peaked at $218K in Q4 2020.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.